Recent News

The patient, treated at Burjeel Hospital, Abu Dhabi, suffered from Adult-Onset Still’s Disease (AOSD), a rare autoimmune condition affecting approximately 1–4 people per million worldwide 

Abu Dhabi: The 34-year-old patient residing in Abu Dhabi had always enjoyed robust health. So, when persistent high-grade fever plagued him for more than two weeks, it was deeply unsettling for him. Despite multiple hospital visits and extensive routine testing, including blood cultures and standard infection screens, the cause of his illness remained unknown, intensifying worries as his condition continued to worsen. With fever, disabling joint pain, extreme fatigue, and evidence of intense inflammation, and liver involvement, his condition started to raise concern as he began to show signs of a potentially life-threatening illness. 

Although he looked stable, the severity and persistence of his symptoms were alarming, prompting the medical team at Burjeel Hospital, Abu Dhabi, to intervene urgently. An in-depth investigation revealed that he was affected by Adult-Onset Still’s Disease (AOSD), a rare autoimmune condition affecting approximately 1–4 people per million worldwide. 

A Difficult-to-Diagnose Disorder  

Dr. Niyas Khalid, Specialist, Internal Medicine, says AOSD is extremely difficult to diagnose because of its rarity and resemblance to other infections. “It mimics many life-threatening diseases such as severe infections, autoimmune disorders, liver disease, and even cancer. It’s often under-recognized, particularly in regions where fever is commonly attributed to infectious causes,” says Dr. Niyas, who treated the patient along with Dr. Abdul Hakeem Muhammed, Specialist, Internal Medicine.  

At the hospital, the patient underwent a series of tests to rule out other possibilities. A major challenge was his body not having rashes, a feature often described in textbooks, but frequently absent or difficult to detect in individuals with darker complexion, adds the doctor.  

In his case, what stood out was the unique combination of prolonged fever, severe inflammation, liver involvement, and extremely high ferritin levels. In addition, all infectious and autoimmune tests had returned negative. “The extraordinarily elevated ferritin, a marker of inflammation, acted as a critical diagnostic signal. When these features came together, along with high-grade fever spiking every day at regular intervals, AOSD became the most plausible explanation, although it is extremely rare,” says Dr. Niyas. 

Fatal if Not Diagnosed in Time 

When affected by AOSD, the patient’s immune system becomes overactive and attacks itself, causing widespread inflammation. If not diagnosed and treated at the right time, the disease can progress to severe complications such as organ damage, chronic inflammatory arthritis, liver failure, or a potentially fatal immune storm known as macrophage activation syndrome. In this case, early intervention was life-altering and, potentially, life-saving. 

“During those days, I shivered from fever and struggled to get up from bed, lift my hands, and move my body. There was no appetite because of throat pain. Despite taking medicine, my fever recurred, draining me emotionally. I prayed to God to give my routine life back,” recalls the patient. 

Rapid Return to Normalcy  

Once AOSD was suspected, the medical team initiated high-dose corticosteroid therapy, the cornerstone treatment for this condition. After the initial high doses, the steroid was tapered carefully over several weeks to suppress the immune reaction while allowing safe recovery. “Within 24 hours, the fever subsided. Within 48 hours, the patient felt significantly better, with improvement in joint pain and energy levels. Laboratory markers improved in parallel,” explains Dr. Niyas. 

“I am so happy that I can move my body without support for the first time after a while. Everyone in the hospital gave me hope whenever I doubted, got frustrated, and questioned myself,” says the patient. 

Although he has recovered remarkably well, ongoing follow-up is essential as AOSD can recur in some patients. He will continue regular follow-up with internal medicine and rheumatology to monitor any signs of relapse and ensure long-term stability. 

Abu Dhabi, UAE, xx June 2026 - Abu Dhabi has marked a global milestone achievement by becoming the first in the world where Camizestrant, a next-generation therapy for advanced breast cancer, has been administered to a patient in a clinical care setting. The treatment is designed to support earlier, more targeted intervention for patients whose cancer has developed resistance to conventional hormone therapy. The achievement reflects Abu Dhabi’s position as a leading destination for best-in-class care, where advanced diagnostics and timely access to specialised treatments are supporting more personalised care. 

Under the supervision of the Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, Burjeel Cancer Institute has administered this novel precision therapy to a woman in her forties diagnosed with advanced breast cancer. The patient was found to have an ESR1 gene mutation, which may cause the cancer to become resistant to conventional endocrine treatment and allow the disease to progress. 

The mutation was detected through circulating tumour DNA (ctDNA) monitoring, a blood-based approach that can identify molecular changes linked to treatment resistance before disease progression becomes visible on scans or through clinical symptoms.  

Camizestrant offers a more targeted treatment option for patients whose cancer has developed ESR1 gene mutation. By providing a more precise and personalised treatment option before clear signs of disease progression appear, it may help to control the cancer for longer, delay further progression and preserve patients’ quality of life. 

Commenting on the achievement, H.E Dr. Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi (DoH) said: The future of healthcare is not defined by treating disease, but by how early we can identify change and intervene before a patient’s condition progresses. Enabling the first global administration of Camizestrant in a clinical setting reflects Abu Dhabi’s vision of building one of the world’s most intelligent and advanced healthcare systems, founded on prevention, early detection, and timely intervention. By accelerating responsible access to advanced therapies with tangible impact at the right time, Abu is enabling precision medicine and more personalised care, improving patient outcomes and reinforcing its position as a leading global destination for healthcare”. 

Prof. Humaid Bin Harmal Al Shamsi, Chief Executive Officer of Burjeel Cancer Institute, added: "We are proud that Burjeel Cancer Institute has become the first centre in the world to treat a patient with this innovative therapy. This milestone reflects Burjeel Cancer Institute’s vision of integrating advanced molecular diagnostics, artificial intelligence, and sophisticated analytical technologies into the patient care pathway, enabling more personalised and precise treatment decisions tailored to the biological characteristics of each individual case." 

He added: "This achievement is not simply about introducing a new drug; it represents the adoption of a comprehensive precision oncology model built on continuous molecular monitoring. Through ctDNA testing, we are now able to detect endocrine therapy resistance at a very early stage and intervene before any radiological or clinical signs of disease progression emerge, giving patients a greater opportunity to control their disease while preserving their quality of life." 

The treatment approach is supported by findings from the global SERENA-6 clinical trial. The study showed that switching patients with an ESR1 mutation detected through ctDNA monitoring to Camizestrant reduced the risk of disease progression or death by 56% compared with continuing conventional endocrine therapy. 

SERENA-6 is the first global registrational trial to use serial ctDNA monitoring to guide a treatment change before radiological or clinical disease progression becomes evident, representing a significant shift in the management of advanced breast cancer. 

Burjeel Cancer Institute continues to strengthen its position as one of the region’s leading centres for oncology and precision medicine by providing advanced molecular diagnostics, multidisciplinary tumour boards, access to innovative therapies and clinical trials, and continued investment in advanced technologies and scientific research. 

This latest global milestone reinforces the Burjeel Cancer Institute’s commitment to providing advanced cancer treatments and scientific innovations to patients, while reflecting Abu Dhabi’s position as a leading destination for specialised care and precision oncology. 

• The clinic provides specialized care to support early diagnosis and effective treatment across workplaces 

Abu Dhabi, June 11, 2026: Lifecare Hospital - Musaffah, part of Burjeel Holdings, has launched a Seasonal Illness Clinic as part of its commitment to expanding specialized services, strengthening prevention, early detection and ensuring timely access to treatment. The clinic aims to support the health and wellbeing of workers and the wider community through integrated diagnostic and therapeutic services.  

The clinic inauguration was held in the presence of H.E. Mansoor Al Mansoori, Chairman of the Department of Health – Abu Dhabi; H.E. Dr. Noura Al Ghaithi, Undersecretary of the Department of Health - Abu Dhabi; Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings; and senior leaders of the Group. The clinic will provide comprehensive and affordable services, including medical assessment, treatment, preventive screening, consultations, patient education and ongoing support to all patients. 

“Musaffah is home to a large and diverse workforce that plays a vital role in the development of the UAE. Ensuring their health and safety is a shared responsibility. Through this clinic, we are bringing specialized infectious disease care, preventive screening, and health education closer to workers and the wider community. This is part of Burjeel Holdings’ commitment to accessible, responsive, and community-focused healthcare,” said Dr. Shamsheer. 

Located in one of Abu Dhabi’s key industrial areas, Lifecare Hospital, Musaffah, has long served as an important healthcare provider for Abu Dhabi’s industrial sector, supporting workers, employers, and surrounding communities with accessible medical services. Led by Dr. Rakesh Kumar Gupta, Consultant in Respiratory Medicine and Medical Director of Lifecare Hospital, Musaffah, the Seasonal Illness Clinic builds on the hospital’s extensive experience and integrated infrastructure, including dedicated isolation facilities when required.  

H.E. Dr. Faisal Al Ahbabi, Executive Director of Communicable Diseases Sector at Abu Dhabi Public Health Centre, said: “The inauguration of the Seasonal Illness Clinic reflects our ongoing efforts to provide specialized services that enhance prevention, early detection and timely intervention. This facility further safeguards the health and wellbeing of community members across the Emirate, reduces the spread of infectious diseases, and enhances the resilience of the healthcare system. This milestone aligns with Abu Dhabi’s vision to build a more proactive, prevention-led ecosystem that is human-centered and enables access to high-quality care for all.”  

The clinic focuses on the diagnosis and management of a range of common conditions, including respiratory and gastrointestinal infections, as well as skin and soft tissue infections, in addition to cases requiring specialized follow-up.  

 Leveraging Burjeel Holdings’ integrated healthcare network, the clinic will enable coordinated access to advanced diagnostic care and comprehensive clinical expertise across the Group’s healthcare network. 

Additionally, the clinic will also work closely with employers, labor accommodations and community groups to support awareness programs, screening campaigns and counseling services. By identifying infections early and ensuring appropriate treatment, the clinic aims to reduce transmission in workplaces and residential settings. 

“Our clinic is designed to extensive structured care, from screening and diagnosis to treatment, counseling, and prevention. We will also focus heavily on educating patients and empowering them to understand how to protect themselves, their families, and their colleagues.” Dr. Rakesh said. 

With the launch of the clinic, Lifecare Hospital Musaffah aims to further strengthen public health support in Abu Dhabi by combining clinical expertise, preventive healthcare, and community outreach in one dedicated service. 

The clinic provides comprehensive diagnosis and treatment of common and underdiagnosed sleep disorders through a multidisciplinary team and advanced diagnostic technologies 

Abu Dhabi, May 9, 2026: Burjeel Medical City, the flagship facility of Burjeel Holdings, has announced the launch of a specialized Sleep Clinic to address sleep disorders, one of the most common health challenges. It marks a significant step in its ongoing commitment to delivering comprehensive healthcare that enhances patients’ quality of life.  

Sleep is not a luxury, but a fundamental physiological necessity. Untreated sleep disorders are associated with serious health complications such as cardiovascular diseases, hypertension, diabetes, and impaired concentration and daily performance. This makes early diagnosis and timely intervention critically important. 

Comprehensive Care for Sleep Disorders 

The Sleep Clinic provides comprehensive services for the diagnosis and treatment of a wide range of sleep disorders through a multidisciplinary team that includes experts in pulmonology, ear, nose and throat (ENT), neurology, cardiology, and psychiatry, ensuring accurate and integrated care for every patient. It addresses a broad spectrum of sleep disorders, including sleep apnea, insomnia, narcolepsy, restless legs syndrome, and circadian rhythm disorders, conditions that often remain undiagnosed despite their significant impact on overall health and quality of life. 

The clinic offers an advanced range of services, including specialized medical consultations and sleep studies conducted both at home and in-lab (PSG), designed to accurately diagnose sleep-related issues and determine their underlying causes. It also provides advanced treatments such as Continuous Positive Airway Pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP), in addition to individualized treatment plans tailored to each patient’s condition.  

Commenting on the launch, Dr. Mujtaba Ali Khan, CEO of Burjeel Medical City, said, “The launch of the Sleep Clinic represents a valuable addition to the advanced care ecosystem at Burjeel Medical City and reflects our continuous commitment to providing integrated healthcare services centered on patients’ needs and quality of life. We believe that sleep health is a fundamental element in both prevention and treatment, and through this clinic, we aim to offer advanced diagnostic and therapeutic solutions that align with the highest international standards.” 

Dr. Humam Schakaki, Consultant in Sleep Medicine and Clinical Lead of Sleep Clinic, stated, “At the Sleep Clinic, we focus on delivering precise and comprehensive evaluations for each case, given the impact of sleep disorders on various body systems. By utilizing the latest sleep study technologies and a multidisciplinary approach, we aim to diagnose conditions early and develop individualized treatment plans that help patients restore healthy sleep patterns and significantly improve their quality of life.” 

The launch of the Sleep Clinic aligns with Burjeel Holdings’ vision to provide advanced healthcare services based on the latest technologies and global best practices, with a strong emphasis on a holistic, patient-centered approach to care.

A minimally invasive surgery at Burjeel Medical City removed part of the lung through a single 3 cm incision

Performed using the da Vinci Xi system, with all three to four robotic arms operating through the same incision

Abu Dhabi, March 23, 2026: Burjeel Medical City has successfully performed the UAE's first uniportal robotic lobectomy, a minimally invasive approach that combines robotic technology with clinical expertise, strengthening Abu Dhabi's position as a leading destination for healthcare innovation focusing on prediction, prevention, and early intervention. The milestone procedure, performed on Jean Erika, a 37-year-old patient with stage one lung cancer, redefines care for patients with early-stage cancer by opening new possibilities and improving outcomes like never before.

Recurring Dry Cough Reveals Cancer

The story of Jean Erika highlights the importance of medical evaluation when symptoms persist. She never imagined that her persistent dry cough, a symptom usually linked to common respiratory conditions, was a possible early sign of underlying cancer. "I had a recurring cough for about three weeks. Despite completing a course of antibiotics, the cough didn't subside," recalls Jean, who has been living in Abu Dhabi for the past eight years. She works as a dental nurse in a private dental center.

A CT scan with dye and a biopsy confirmed carcinoma. Her condition was discussed in a Multidisciplinary Tumor board meeting where it was decided that the best way forward was surgery. Following this, she consulted Dr. Taj Mohammed Fiyaz Chowdhry, Consultant Thoracic Surgeon, who suggested a uniportal robotic 3 cm lobectomy.

It is a procedure where a part of the lung is removed through a single 3 cm incision, with all three or four robotic arms going through the same incision.

Dr. Taj Mohammed Fiyaz Chowdhry

Consultant Thoracic Surgeon

Jean felt anxious about surgery, especially with a robot performing it. “But the doctor explained that robotic surgery would mean faster recovery and smaller wounds, which helped me feel reassured,” says Jean, who prepared herself for the surgery with the support of the medical team as well as her friends. “The entire team, including the anesthesiologist, met with me before the surgery and explained everything clearly. They made me feel comfortable and confident.”

Minimally Invasive Surgery, Faster Recovery

The surgery led by Dr. Taj lasted about four hours. He was accompanied by Dr. Nermeen Said Hassanin, Consultant Anesthesia, and Mr. Renukesh, Robotic Surgery Nurse Specialist. The team used the da Vinci Xi system, which provides precision, control, and minimally invasive access. While Dr. Chowdhry operated on the console, an experienced assistant supported the patient's side. The anesthesia team ensured the lung was isolated and the patient remained stable.

The surgery went smoothly without complications. "Normally, patients are discharged five to seven days after a traditional lobectomy. However, she was fit for discharge just two days after surgery due to minimal dissection and reduced surgical stress," says the doctor.

I realized how advanced UAE healthcare has become. As a nurse, I really appreciate how robotic surgery causes minimal scarring and less pain, and allows faster recovery, letting patients return to their normal lives sooner. At BMC, everything was efficient, and the facilities were excellent. The staff were very supportive and accommodating. They took care of all my needs and made sure I felt comfortable throughout.

Jean Erika

Patient and Dental Nurse

Jean returned to work one month after surgery.

Breakthrough in Early-Stage Cancer Care

According to Dr. Chowdhry, this approach is best suited for early stages of cancer. "For Jean, this method was chosen because she had early-stage cancer with no significant lymph node involvement and had not undergone chemotherapy or immunotherapy.

It is generally preferred not to perform this surgery on patients who have previously received chemotherapy or with bulky lymph node disease, as these factors may make it technically difficult to perform through uniportal.

Dr. Taj Mohammed Fiyaz Chowdhry

Consultant Thoracic Surgeon

BMC has been at the forefront of its robotic program since the deployment of the da Vinci system. This accomplishment reflects the strength of its multidisciplinary teams in advancing minimally invasive surgery and highlights the vision behind establishing a world‑class advanced thoracic surgery department within the facility.

•  In spite of rain, Burjeel Holdings’ frontline healthcare workers from 64 nationalities united under one banner in a powerful tribute to the UAE during the Group’s annual sports event, Burjeel Games 

• Carrying a banner measuring 85 meters and weighing over 200 kilograms, they covered a distance of 100 meters, surpassing the previous record of 58 nationalities set in Dubai in 2019 

Abu Dhabi, April 11, 2026: For weeks, they remained on the frontlines, delivering care when it mattered most. On Saturday evening, they gathered once again. However, this time, it was not in hospitals, but on a sports ground, under one banner, united for the UAE. 

In a unique tribute reflecting the nation’s spirit of solidarity, frontline healthcare workers from Burjeel Holdings, a leading super-specialty healthcare provider in the MENA region, set a Guinness World Record for the ‘Most Nationalities Carrying a Banner’, bringing together 64 nationalities in a single coordinated formation at Abu Dhabi’s Hudayriyat Island. The day witnessed rain. Despite it, people poured in by the evening and stood firm in support of the nation.  

Held during the closing ceremony of the Burjeel Games, the Group’s annual sports event in collaboration with Abu Dhabi Sports Council (ADSC), the initiative themed “Our Nation. Our Heartbeat.” transformed a sporting finale into a moment of national reflection. It was inspired by the UAE leadership’s call to raise the national flag and reinforce unity across the country. Organized within 48 hours, it became the first record-breaking event to be staged in the region after the nation reaffirmed its strength following the change in circumstances.  

A Guinness Record of Unity, Diversity, and Resilience

At the venue, the participants carried a single banner measuring 85 meters and weighing over 200 kilograms. A total number of 153 people, including the 64 unique nationalities, walked a distance of 100 meters while holding it overhead, surpassing the previous record of 58 nationalities set in Dubai in 2019. 

Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings, described the initiative as a reflection of both the UAE’s resilience and the commitment of its healthcare workforce. “We are proud to be part of a nation that brings together so many cultures under one vision. This initiative represents the resilience of the UAE and the strength of its people. In the past weeks, we have stood alongside the nation, serving communities with commitment and care. This moment reflects that same spirit, a collective expression of unity from people who call this country home,” he said. 

The attempt adhered to strict Guinness World Records guidelines, with each participant representing a unique nationality and completing the required distance in a synchronized formation. Mr. Raafat Tawfik, the official Guinness World Records adjudicator present on-site, reviewed the attempt and confirmed its success. “We are officially congratulating you on the 64 nationalities,” the adjudicator announced.  

His Excellency Aref Hamad Al Awani, Secretary-General of the Abu Dhabi Sports Council, affirmed that this achievement reflects the growing stature of Abu Dhabi as a global hub for sports and community events that blend athletics with human and national values. 

“Our partnership with Burjeel Holdings aligns with the Council’s ongoing efforts and strategic direction to support events that foster a spirit of unity and social cohesion, while highlighting the positive role of sports as a bridge connecting diverse cultures and nationalities under the banner of the UAE. Achieving a world record of this scale embodies the UAE’s message of tolerance and coexistence. It underscores that sports is not just about competition, but also a platform to celebrate diversity, teamwork, and community service,” he said. 

A Moment Deferred, Then Reimagined 

The Burjeel Games, one of the UAE’s largest healthcare sports and community events with over 2,500 participants, was originally set to conclude on February 28. However, in light of regional circumstances at the time, the final was postponed. 

As the situation evolved and the nation emerged stronger, the Burjeel community reconvened to complete the Games in a meaningful way. The finale became a platform for a larger expression, a record-setting tribute to the country that unites them. 

From Frontlines to a Moment of Unity 

For many of the participants, the moment carried deeper meaning. “Our usual days include focusing on care and being present for every patient who needs us,” said Dr. Michael George Uglow from Burjeel Medical City, a native of United Kingdom. “Today, we came together differently, as proud members of the UAE, standing under one banner.” 

Dirkie Theunissen, Group Chief Nursing Officer, who hails from South Africa, reflected on the diversity. “We work side by side with colleagues from across the world every day. Today, that diversity came alive in a powerful way. It reminded us why the UAE feels like home.” 

The initiative highlights Burjeel Holdings’ commitment to celebrating the multicultural fabric of the UAE, which is home to more than 200 nationalities, and supporting national values of unity and harmony. 

Chairman and CEO Dr. Shamsheer Vayalil announces major frontliner recognition fund during leadership address in Abu Dhabi

Abu Dhabi, January 20, 2026: What was planned as a leadership address became an emotional moment for thousands of healthcare workers as Burjeel Holdings Chairman and CEO Dr. Shamsheer Vayalil announced AED 15 million financial recognition fund during a Group-wide town hall attended by more than 8,500 employees at Etihad Arena.

The gathering marked a first-of-its-kind moment in the UAE, with one of the country’s largest CEO-led employee town halls bringing together frontline staff, clinicians, nurses, allied health professionals, and support teams under one roof. Midway through the address, employees’ phones began buzzing with SMS notifications confirming their inclusion in the newly launched BurjeelProud recognition initiative, prompting sustained applause across the arena.

“This is not a reward for a department. This is not tied to conditions. This is not because you asked. This is because you are the people on the ground,” Dr. Shamsheer told employees.

AED 15 Million Surprise for Frontliners

Close to 10,000 frontline employees will benefit from the first phase of the initiative, covering nearly 85 percent of Burjeel Holdings’ nursing, allied health, patient care, operations, and support workforce. The financial recognition is expected to be equivalent to approximately half a month to one month of basic salary, depending on role and category.

“This country gave us the opportunity to grow. And when a country gives you that opportunity, you carry a responsibility to give back with action,” he said.

He described frontliners as central to Burjeel’s identity and future direction. “I will not be able to stand here if you are not there on the ground,” he told employees.

The announcement came as a surprise to many in attendance, with several frontline staff seen emotional as the timing and message became clear. “It was a real surprise. It felt like a moment for all of us on the frontline,” said one nurse after the event.

The recognition initiative forms part of Burjeel Holdings’ next phase of growth, Burjeel 2.0, with a focus on execution, accountability, and people-led growth.

Burjeel Medical City to Evolve into Next-gen Ecosystem

The address also outlined Burjeel’s 2030 vision for Burjeel Medical City (BMC), which will evolve into a next-generation medical city ecosystem in Mohammed Bin Zayed City. The expansion aims to move beyond a traditional hospital model by integrating complex clinical care with research, medical education, rehabilitation, and patient-centered living environments.

“I still remember standing with a small model of Burjeel Medical City and sharing that vision with His Highness Sheikh Mohamed bin Zayed Al Nahyan during his visit years ago. It was only a

dream then. Today, it stands as one of the most important healthcare institutions in the region,” Dr. Shamsheer said.

Aligned with Abu Dhabi’s long-term healthcare strategy, the BMC vision includes an advanced academic medical model combining patient care, education, and research, alongside specialized institutes such as sports medicine and rehabilitation services.

The recognition positions the Group as a national and regional leader in advanced nursing education 

Abu Dhabi: Burjeel Holdings, a leading super-specialty healthcare services provider in MENA, has achieved a landmark milestone in healthcare education and workforce development by securing the National Institute for Health Specialties’ (NIHS) accreditation for its Adult Critical Care Nursing Residency Program.  

It is the first NIHS-accredited Nursing Residency Program in the UAE and the region, and the first officially recognized nursing residency program in the country, positioning the Group as a national and regional pioneer in advanced nursing education. 

“The accreditation reflects Burjeel Holdings’ commitment to advancing healthcare education and building sustainable national capabilities. Investing in structured, accredited training, particularly in critical care nursing, is essential to strengthening healthcare quality, resilience, and patient safety across the UAE and the wider region,” said Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings. 

Dr. Mohamed Al Houqani, Secretary General of NIHS, said that the accreditation represents an important milestone in regulated nursing education in the UAE. “It reflects NIHS’ commitment to strengthening specialty-based training, elevating professional practice standards, and supporting a sustainable, highly skilled healthcare workforce that meets national priorities and international benchmarks,” he said. 

Residency Program to Empower Nursing Workforce  

The residency program prepares nurses for advanced clinical practice in Adult Critical Care, in alignment with national regulatory requirements and international best practices. Graduates will receive NIHS accreditation in the specialty of Adult Critical Care Nursing, enabling them to practice at the highest standards of clinical excellence. 

Beyond its accreditation significance, this program represents a fundamental shift in the nursing practice model in the UAE. By transitioning from task-based nursing roles to structured, competency-based, residency-trained practice, the program strengthens clinical decision-making, professional accountability, and interdisciplinary collaboration. This approach directly contributes to improved patient outcomes, enhanced quality of care, and safer critical care environments. 

“This program represents a milestone in our journey to reshape medical education in the UAE. By embedding structured, nationally accredited residency training into nursing career pathways, we are raising professional standards, strengthening quality and safety in critical care, and building a strong, sustainable nursing workforce equipped for the future of healthcare,” commented Dr. Tahani Al Qadiri, Director of Emiratization and Academic Affairs at Burjeel Holdings. 

Investing in medical education will ensure long-term workforce sustainability by establishing a clear professional career pathway for healthcare professionals, supporting retention, specialization, and leadership development. Through nationally accredited residency training, the program reduces reliance on ad hoc upskilling models and creates a future-ready workforce aligned with the UAE’s healthcare transformation agenda.  

This achievement builds on Burjeel Holdings’ proven leadership in medical education, marked by a series of nationally recognized milestones. Over recent years, the Group has successfully secured multiple NIHS accreditations across residency and fellowship programs, including the internal medicine, general surgery, orthopedic, and hematology-oncology programs. It established structured competency-based training pathways and expanded accredited education within the private healthcare sector.   

Through this achievement, Burjeel Holdings continues to set new benchmarks in healthcare education, reinforcing its leadership in clinical excellence, accredited training, quality improvement, and national workforce sustainability. 

BCI achieved a flawless result with no findings or non-conformities, marking an exceptional accomplishment

Abu Dhabi, November 13, 2025: In a landmark medical achievement, Burjeel Cancer Institute’s (BCI) Breast Cancer Clinical Care Program has received the Gold Certification from the Joint Commission International (JCI). The JCI Gold Certification, considered a global benchmark in healthcare excellence, is granted only to institutions that demonstrate the highest international standards in clinical care delivery. The accreditation acknowledges BCI’s strong commitment to continuously improving the delivery of quality healthcare services.

As part of the evaluation process, JCI’s expert panel visited the institute for a comprehensive and rigorous assessment. It involved an in-depth review of compliance with 164 measurable standards covering all aspects of cancer care, including leadership and governance, care delivery, patient safety, information and medication management, staff training and competency, as well as patient and family education.

BCI distinguished itself by achieving a flawless result with no findings or non-conformities, marking an exceptional accomplishment that highlights the dedication and professionalism of its team in delivering world-class cancer care.

Commenting on the achievement, Prof. Humaid bin Harmal Al Shamsi, CEO of BCI, said, “Receiving the JCI Gold Certification for our Breast Cancer Program is an international endorsement of the quality of care we provide and our commitment to advancing healthcare excellence in our region. This recognition is not merely an institutional milestone; it is a renewed promise to our patients that we remain devoted to offering comprehensive, safe, and compassionate care that meets global standards. We take pride in leading innovation and excellence in cancer care.”

The certification provides a robust institutional framework to enhance patient experience, improve staff efficiency, and ensure consistent and safe healthcare delivery. It also supports patient-centered care strategies and reinforces the institute’s commitment to addressing the physical, psychological, and social needs of patients and their families.

Established in 1994 as an affiliate of the Joint Commission (USA), Joint Commission International (JCI) is a globally recognized leader in healthcare accreditation. Operating in more than 70 countries, JCI promotes quality improvement and patient safety through rigorous accreditation programs and internationally recognized standards. For more information, visit: www.jointcommissioninternational.org

The Group won awards in the ‘Establishments’ and ‘Outstanding Workforce’ categories, reaffirming its commitment to developing a dynamic and healthy workplace 

Abu Dhabi, November 14, 2025: Strengthening its reputation for workplace excellence, Burjeel Holdings, a leading super-specialty healthcare provider in the MENA region, has secured two awards at the third edition of the prestigious Emirates Labour Market Awards. Organized by the Ministry of Human Resources and Emiratisation (MOHRE), the ceremony was held under the patronage of His Highness Sheikh Mansour bin Zayed Al Nahyan, Vice President, Deputy Prime Minister, and Chairman of the Presidential Court. 

In the Establishments category, LLH Hospital, Abu Dhabi, received recognition in the Healthcare Company sub-category. For LLH Hospital, this marks a hat-trick win at the Labour Market Awards. In the inaugural edition, it was honored for its outstanding achievement in Workforce Well-being and the Quality of Life category, followed by the Establishments — Healthcare and Social Work category in the second edition.  

The Group also excelled in the Outstanding Workforce category, with Anas Kadiyarakam, Regional HR Manager at Burjeel Holdings, securing first place in the Management and Executives sub-category. He received a cash prize of one hundred thousand dirhams, an Apple Watch, a gold coin, and a Fazaa privilege card.  

The winners were honoured by His Highness Theyab bin Mohamed bin Zayed Al Nahyan, Deputy Chairman of the Presidential Court for Development and Fallen Heroes’ Affairs. 

Anas, a first-time recipient of this award, said that it’s a proud milestone in his career. He started his journey at Burjeel Holdings in 2009 as an HR Executive. From there, he was promoted to the roles of HR Officer, Assistant Manager, and then Manager. Currently, he serves as the Regional HR Manager, overseeing hospitals and international projects across the region. “I feel so honored to receive this prestigious award. I consider it a recognition from the UAE for being part of its labor force for the past 16 years. I’m also thankful to the Burjeel family for providing me with amazing opportunities that have catalyzed my career growth and enabled me to contribute to the overall development of the nation. This award also serves as a powerful reminder to continue creating a healthy workplace where people can thrive,” he said. 

Reflecting on the achievement, Dr. Tahani Al Qadiri, Group Director of Emiratization and Academics at Burjeel Holdings, said, “We feel immensely proud to receive this esteemed recognition once again, which honors the continuous efforts we put forward in building an inclusive, sustainable, and empowering workplace. At Burjeel Holdings, we remain focused on investing in our people, as we know they are the driving force behind exceptional care and innovation in healthcare. This honor inspires us to continue cultivating a healthy workforce and, in doing so, contribute to the UAE’s vision of cultivating world-class work environments.” 

The winners, comprising companies and individuals, were chosen from over 18,000 applications, reviewed by expert committees using comprehensive and integrated criteria. 

Over 700 specialists gather at the Fourth Emirates Pediatric BMT and Gene Therapy Congress to share breakthroughs, celebrate treatment success, and strengthen the UAE’s position as a hub for advanced pediatric care. 

Abu Dhabi, November 8, 2025: Reinforcing the UAE’s ambition to emerge as a global leader in advanced pediatric care and its growing reputation as a hub of medical excellence and innovation, Abu Dhabi hosted the Fourth Emirates Pediatric Bone Marrow Transplantation and Gene Therapy Congress, which opened today at the Grand Hyatt Abu Dhabi Hotel & Residences. The two-day congress brings together global leaders in pediatric hematology, oncology, and cellular therapy, underscoring the nation’s vision to position itself at the forefront of complex and life-saving medical treatments. 

This year’s congress, themed “An International Get-Together of Pediatric BMT Physicians to Celebrate the Success of Saving Children Globally,” reflects the spirit of collaboration and shared progress that defines the global pediatric bone marrow transplant community. The theme highlights the dedication of physicians, researchers, and healthcare institutions working together to advance curative treatments for children with rare and life-threatening blood disorders. 

A Two-Day Comprehensive Scientific Program 

The congress brings together more than 700 delegates and over 30 distinguished speakers from across 30 countries, including the United States, the United Kingdom, Spain, France, Italy, Saudi Arabia, India, and Jordan. Participating institutions include Burjeel Medical City (BMC), Children’s Hospital of Philadelphia, Cincinnati Children’s Hospital, Children’s Hospital Los Angeles, and SJD Barcelona Children’s Hospital. 

This year’s congress features a comprehensive scientific program encompassing keynote lectures, expert panels, oral and poster presentations, and industry symposia. Topics being discussed include the latest advances in gene therapy for thalassemia and sickle cell disease, haploidentical and matched sibling transplantation, CAR-T cell therapy, and transplant immunology. Sessions also explore donor stem-cell manipulation, supportive care, long-term survivorship, and regional access to cell and gene therapy innovations. 

The congress also focuses on the UAE’s growing contributions to regional healthcare advancement, including the development of national stem cell donor registries, collaboration with the Abu Dhabi Biobank to enhance cell therapy research, and strategies to increase access to gene therapy and transplantation across the Gulf region. 

Ahead of the main sessions, the Pediatric Bone Marrow Transplant Course 2025 offered intensive hands-on and theoretical training for young clinicians and researchers in pediatric transplantation. Led by international faculty, the course covered donor selection, stem cell harvesting and cryopreservation, conditioning regimens, and post-transplant management, equipping participants with practical skills to strengthen regional capacity. 

“This congress reflects how far we have come as a region in advancing pediatric transplantation and gene therapy. Supporting this significant event, our goal at BMC, is to provide children and families in the UAE and across the region with access to the best possible care, without the need to travel abroad. Along with the treatment center we are strengthening research, and collaboration that drives new standards in pediatric care,” said Dr. Zainul Aabideen, Congress Chair and Head of Pediatric Hematology, Oncology, and Bone Marrow Transplantation at Burjeel Cancer Institute, BMC. 

Dr. Aabideen presented to the delegates how BMC, which became home to the UAE’s first comprehensive pediatric bone marrow transplant program, has achieved survival rates of over 90 percent in the past three years. The milestone underscores Abu Dhabi’s emergence as a regional referral destination for complex pediatric cases and aligns with the UAE’s broader healthcare strategy to build self-sufficiency through advanced clinical capabilities and local talent development. 

Delegates reaffirmed their shared goal of advancing knowledge, expanding research collaboration, and accelerating access to gene therapy for children with rare and inherited disorders. With its focus on innovation, education, and global partnership, the congress celebrates the collective success of pediatric bone marrow transplant programs worldwide and underscores the UAE’s leadership in shaping the future of pediatric medicine. 

KSA Health Minister HE Fahad Abdulrahman AlJalajel, felicitated Dr. Shamsheer Vayalil, Founder and Chairman of the Group, for initiatives advancing healthcare transformation in line with Vision 2030.

Riyadh, October 28, 2025: Burjeel Holdings, a leading super-specialty healthcare services provider in MENA, unveiled a suite of advanced artificial intelligence (AI) solutions at the Global Health Exhibition 2025 in Riyadh, underscoring its commitment to transforming patient care and advancing Saudi Arabia’s healthcare ecosystem.

During the opening ceremony, HE Fahad Abdulrahman AlJalajel, Minister of Health, felicitated Dr. Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings, for the Group’s initiatives that advance healthcare transformation in line with Saudi Arabia’s Vision 2030.

Integrating Care and Intelligence

Under the theme ‘Care & Intelligence – World-Class Healthcare for the Kingdom,’ Burjeel Holdings is showcasing how technology, data, and empathy converge to redefine healthcare experiences. The Group is demonstrating a new generation of AI-driven innovations designed to elevate patient outcomes, streamline clinical workflows, and support wellness through personalized, data-informed care models.

“The Global Health Exhibition provides an important platform to demonstrate how care and intelligence can come together to reshape the healthcare experience. With these integrated AI-driven healthcare innovations, we are building a smarter, more compassionate healthcare future that meets the evolving needs of our patients and communities. Our goal is to seamlessly blend cutting-edge technology with human-centered care to elevate health outcomes and quality of life across the region,” said Mr. Safeer Ahamed, Co-CEO of Burjeel Holdings.

The newly introduced AI solutions span a wide spectrum of applications, from digital rehabilitation platforms that enable patients to undergo guided physiotherapy from home to intelligent surgical systems that connect specialists virtually to perform and supervise procedures in real time. These innovations combine clinical expertise with automation and analytics to ensure accuracy, safety, and accessibility in every phase of care.

Another key innovation focuses on predictive and personalized health management. Through data modeling and biomarker analysis, the Group’s new digital health platforms can identify early risks, optimize preventive care, and generate tailored lifestyle and nutrition insights. This approach allows clinicians to transition from reactive to proactive care models, improving health outcomes and patient satisfaction.

Advancing Personalized, Preventive, and Mental Health Solutions

In musculoskeletal and rehabilitation care, Burjeel Holdings continues to deploy personalized and digital therapeutics that deliver home-based physiotherapy and pain management programs. These solutions use real-time monitoring to ensure continuous recovery support and data-driven therapy optimization.

In specialty and complex care, the Group continues to advance precision medicine through diagnostic and therapeutic programs that leverage molecular and clinical data. Collaborations

with international partners and ongoing clinical trials are helping bring personalized treatments and innovative therapies to patients across the region.

To promote holistic health and longevity, Burjeel Holdings is introducing digital platforms that combine genetic, biomarker, and lifestyle data to provide actionable insights and personalized recommendations for nutrition, fitness, and preventive care. Complementing these initiatives, the Group is integrating empathetic AI-powered companions that support mental and emotional well-being through guided assistance and culturally attuned digital engagement.

Across its facilities, the Group is also integrating generative AI tools that improve clinical workflows and communication between patients and care teams. These intelligent systems enhance efficiency, safety, and patient experience, reflecting the Group’s vision to make healthcare more connected, compassionate, and data-driven.

Since entering the Kingdom three years ago, Burjeel Holdings has evolved from a regional healthcare leader to a trusted local partner. Its brands, including PhysioTherabia and Al Kalma, have established a strong presence across wellness and mental health services. Al Kalma’s recent acquisition of a leading mental health facility in Riyadh further underscores the Group’s dedication to expanding access to emotional and psychological support. Burjeel Holdings is also preparing to open two new day surgery centers in Riyadh and Al Khobar under its Burjeel One brand, offering world-class outpatient and same-day surgical care.

These innovations reflect Burjeel Holdings’ vision of building a more connected, efficient, and patient-centric healthcare ecosystem across the Kingdom. The solutions are being integrated within the Group’s expanding network across the region to improve access, enhance clinical training, and reduce the burden of chronic and lifestyle-related diseases. These developments reinforce the Group’s role as a key contributor to Saudi Arabia’s efforts to localize advanced healthcare capabilities and expand digital health infrastructure.